What's breaking now, across thousands of outlets.
TOKYO (Jiji Press) — An advisory panel to the health minister on Friday approved public health insurance coverage for an injection version of lecanemab, an Alzheimer’s medicine developed by Eisai Co. and Biogen Inc., and its administration at patients’ homes, effective Nov. 13.
We haven't written up this one. The Japan News by The Yomiuri Shimbun has the full story — the link below goes straight to it.
Health Ministry data show one in three Israelis ages 65-84 has diabetes, with higher rates and poorer control among Arab and low socioeconomic groups; Ichilov's Prof.
New Delhi: The Delhi Directorate of Education has directed all government and private schools to conduct classes up to class 5 in hybrid mode in view of worsening air quality in the national capital.
Mumbai: The Maharashtra Food and Drug Administration (FDA), led by Tukaram Munde, has also taken action against Blinkit and Zepto as part of its ongoing pre-Diwali actions against food outlets…
St. Joseph’s Church in Kuriachira, Thrissur, has set up an open gym to promote fitness among parishioners. With no fixed timings, parishioners can drop in at their convenience, with many heading to…
Abu Dhabi: Surgeons in Abu Dhabi have removed a rare cancerous tumour weighing 4.4 kilograms and measuring 36 centimetres from a 49-year-old patient during a six-hour operation that involved the…
The Pharmacy and Poisons Board (PPB) has cautioned Kenyans against taking excessive doses of cetirizine, warning that misuse of the commonly used allergy medication could expose users to serious…
